Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Looking back at Cannabis research.

R Mechoulam1

  • 1Hebrew University, Medical Faculty, Department of Medicinal Chemistry and Natural Products, Jerusalem, 91120, Israel. mechou@cc.huji.ac.it

Current Pharmaceutical Design
|July 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the molecular basis of cannabidiolic acid methyl Ester's anti-depressive effects in a rat model of treatment-resistant depression.

Journal of psychiatric research·2024
Same author

Acute oral cannabidiolic acid methyl ester reduces depression-like behavior in two genetic animal models of depression.

Behavioural brain research·2018
Same author

Cannabis and epilepsy.

Epilepsy & behavior : E&B·2017
Same author

In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.

Current oncology (Toronto, Ont.)·2016
Same author

Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress.

Cell death & disease·2012
Same author

The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex.

British journal of pharmacology·2012
Same journal

Fentanyl and its Analogs: A Medicinal Chemistry Perspective on Therapeutic Potential and Abuse Liability.

Current pharmaceutical design·2026
Same journal

Acne Vulgaris: Integrating Pathophysiology with Conventional, Herbal, and Nanocarrier-Based Therapeutic Strategies.

Current pharmaceutical design·2026
Same journal

Systems Pharmacology and Pharmaco-Transcriptomic Insights into Bauhinia variegata for Polycystic Ovary Syndrome Management.

Current pharmaceutical design·2026
Same journal

Curcumin and Cognitive Health: Insights from Randomized Controlled Trials.

Current pharmaceutical design·2026
Same journal

Inorganic Materials-integrated Porphyrin for Drug Delivery in Cancer Therapy: Promises, Challenges and Outlooks.

Current pharmaceutical design·2026
Same journal

Precision Nanotechnology in Oral Oncology: From Biomarker-Guided Targeting to AI-Driven Theranostics.

Current pharmaceutical design·2026
See all related articles

This research details the discovery of plant and endogenous cannabinoids. Investigations focus on synthetic cannabinoids HU-211 for neuroprotection and HU-308 as a CB2 agonist.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Organic Chemistry

Background:

  • The 1960s saw the isolation of plant cannabinoids, initiating research into their effects.
  • The 1990s marked a significant advancement with the discovery of endogenous cannabinoids.
  • Understanding cannabinoid systems is crucial for therapeutic development.

Observation:

  • This study reviews the historical isolation of plant and endogenous cannabinoids.
  • It examines synthetic cannabinoids, specifically HU-211 and HU-308.
  • HU-211 is identified as a neuroprotective agent.

Findings:

  • HU-211 demonstrates neuroprotective properties.
  • HU-308 is characterized as a specific agonist for the CB2 receptor.
  • These synthetic compounds offer distinct therapeutic potentials.

Related Experiment Videos

Implications:

  • The findings contribute to the understanding of the endocannabinoid system.
  • Synthetic cannabinoids like HU-211 and HU-308 present potential therapeutic applications.
  • Further research into these compounds could lead to novel treatments for neurological disorders and inflammatory conditions.